METHOD OF TREATING PATIENTS SUFFERING FROM COMMUNITY-ACQUIRED PNEUMONIA Russian patent published in 2015 - IPC A61N5/67 

FIELD: medicine.

SUBSTANCE: prescribing a complex of medicinal products is combined with exposing the patient's blood intravenously to a continuous laser light generated by the Matrix-VLOK apparatus. The medicinal products involve antibacterial and mucolytic preparations; a detoxification therapy is also conducted. If observing a moderate clinical course of community-acquired pneumonia in a combination with lactoferrin measured at 2,420 ng/ml and 34% spontaneous and 55% stimulated nitro blue tetrazolium test results, 7 procedures of the 5-minute intravenous laser exposure of the patient's blood are required. A laser light wavelength is 0.405 mcm; an output power at an end face of a disposable intravenous light guide is 1.0 mW.

EFFECT: method enables increasing the clinical effectiveness in community-acquired pneumonia by normalising functional-metabolic neutrophil activity indices, reducing the inflammatory process activity and drug-induced load on the patient.

2 ex